Description

Growth Hormone Deficiency Market Overview

Growth Hormone Deficiency Market Size is expected to reach USD 6.21 Billion by 2033. The Growth Hormone Deficiency industry size accounted for USD 18.33 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 4.21% from 2023 to 2033. The growth hormone deficiency market focuses on the treatment of conditions where the body does not produce sufficient growth hormone, leading to stunted growth and other health issues. This market includes diagnostic tests and therapeutic treatments such as recombinant growth hormone therapies. Key drivers include increasing awareness of the condition, advancements in biotechnology, and rising prevalence of growth hormone deficiency. The market is segmented by treatment type, end user (hospitals, clinics, and home care settings), and geography. Growth is fueled by innovations in drug formulations and delivery systems, as well as expanding healthcare infrastructure.

Global Growth Hormone Deficiency Market Synopsis

COVID-19 Impact Analysis

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Growth Hormone Deficiency market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.

Global Growth Hormone Deficiency Market Dynamics

The major factors that have impacted the growth of Growth Hormone Deficiency are as follows:

Drivers:

⮚ Advancements in Biotechnology

Innovations in biotechnology, such as the development of recombinant DNA technology, have led to the creation of more effective and safer growth hormone therapies. These advancements have expanded treatment options and improved patient outcomes, contributing to market growth.

Restraint:

Adverse Effects and Safety Concerns

Although generally safe, growth hormone treatments can have side effects such as joint pain, fluid retention, and increased risk of diabetes. Concerns about long-term safety and potential adverse effects can impact patient compliance and healthcare provider recommendations.

Opportunity:

⮚ Personalized Medicine

The trend towards personalized medicine offers opportunities to tailor growth hormone treatments based on individual genetic profiles and specific patient needs. Personalized approaches can improve treatment outcomes and drive demand for customized therapeutic solutions.

Growth Hormone Deficiency Market Segment Overview

By Brands

Based on the Brands, the market is segmented based on Genotropin, Norditropin, Humatrope, Saizen, Omnitrope, Others. Genotropin dominates the brand segment due to its strong market presence and established reputation for efficacy in growth hormone therapy.

By Route of Administration

Based on Route of Administration, the market has been divided into Subcutaneous, Intramuscular, Intravenous, Oral, Others. subcutaneous administration dominates the route of administration segment due to its ease of use and effectiveness in delivering growth hormone therapies.

By Application

Based on the Application, the market has been divided into Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others. Growth Hormone Deficiency (GHD) dominates the application segment, as it is the primary indication for growth hormone therapies and encompasses a broad patient base.

By Distribution Channel

Based on Distribution Channel, the market has been divided into Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites, Others. hospital pharmacies dominate the distribution channel segment due to their role in providing specialized medications and comprehensive patient care for chronic conditions.

Global Growth Hormone Deficiency Market Regional Analysis

Based on region, the market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. The area of North America is anticipated to dominate the market for the usage of Growth Hormone Deficiency, followed by those in Asia-Pacific and Europe.

Growth Hormone Deficiency North America Market

The North American region holds a dominant position in the Growth Hormone Deficiency market. In 2022, the growth hormone deficiency market in America held the biggest market share. Its substantial stake is mainly due to the region’s abundance of market participants, growing technology advancements, and well-developed healthcare infrastructure.

Growth Hormone Deficiency Asia Pacific Market

The Asia-Pacific region is witnessing rapid growth and emerging as a significant market for the Growth Hormone Deficiency industry. The market for growth hormone deficiency is anticipated to expand at the quickest rate in the Asia-Pacific region between 2023 and 2032 as a result of rising treatment advancements, more funding for research, and an increase in the prevalence of GHD. Furthermore, the growth hormone deficiency market in China accounted for the greatest market share, while the market in India is anticipated to grow at the fastest rate in the Asia-Pacific region.

Competitive Landscape

The competitive landscape includes key players (tier 1, tier 2, and local) having a presence across the globe. Companies such as Novo Nordisk A/S, Pfizer Inc, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, and Biopartners GmbH are some of the leading players in the global Growth Hormone Deficiency Industry. These players have adopted partnership, acquisition, expansion, and new product development, among others as their key strategies.

Key Market Players:

Novo Nordisk A/S
Pfizer Inc
Novartis AG
Anhui Anke Biotechnology (Group) Co., Ltd
Biopartners GmbH
Ipsen S.A.
Eli Lily And Company
Merck KGaA
GeneScience Pharmaceuticals Co., Ltd
Lifetech Labs

Key Development:

In September 2020, Novo Nordisk received US Food and Drug Administration approval for Sogroya (somapacitan). The drug is used in the treatment of adults suffering from growth hormone deficiency.

Scope of the Report

Global Growth Hormone Deficiency Market, by Brands

Genotropin
Norditropin
Humatrope
Saizen
Omnitrope
Others

Global Growth Hormone Deficiency Market, by Route of Administration

Subcutaneous
Intramuscular
Intravenous
Oral
Others

Global Growth Hormone Deficiency Market, by Application

Growth Hormone Deficiency
Idiopathic Short Stature
Small for Gestational Age
Turner Syndrome
Prader-Willi Syndrome
Others

Global Growth Hormone Deficiency Market, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Clinics
E-Commerce Websites
Others

Global Growth Hormone Deficiency Market, by Region

North America
- US
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia Pacific
- China
- Japan
- South Korea
- Indonesia
- Austalia
- Malaysia
- India
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of Middle East & Africa

Parameters	Indicators
Market Size	2033: $6.21 Billion
CAGR	4.94% CAGR (2023-2033)
Base year	2022
Forecast Period	2023-2033
Historical Data	2021
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations	Brands, Route of Administration, Application, Distribution Channel
Geographies Covered	North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors	Novo Nordisk A/S, Pfizer Inc, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A., Eli Lily And Company, Merck KGaA, GeneScience Pharmaceuticals Co., Ltd, Lifetech Labs
Key Market Opportunities	Strong pipeline of hormonal drugs Easy availability of pharma drugs on E-commerce platforms
Key Market Drivers	Increasing cost of GHD Increasing counterfeit products for GHD treatment Rising number of strategic initiatives

REPORT CONTENT BRIEF:

High-level analysis of the current and future Growth Hormone Deficiency Industry trends and opportunities
Detailed analysis of current market drivers, restraining factors, and opportunities analysis in the future
Historical market size for the year 2021, and forecast from 2023 to 2033
Growth Hormone Deficiency market share analysis for each segment
Competitor analysis with a comprehensive insight into its product segment, financial strength, and strategies adopted.
Identifies key strategies adopted by the key players including new product development, mergers and acquisitions, joint ventures, collaborations, and partnerships.
To identify and understand the various factors involved in the global Growth Hormone Deficiency market affected by the pandemic
To provide year-on-year growth from 2022 to 2033
To provide short-term, long-term, and overall CAGR comparison from 2022 to 2033.
Provide Total Addressable Market (TAM) for the Global Growth Hormone Deficiency Market.

For more details mail us at

[email protected]

Ask a question / additional requirement

Frequently Asked Questions (FAQ)

1. What is the study period of this market?

The study period of the global Growth Hormone Deficiency market is 2022- 2033

2. What are the 10 Years CAGR (2023 to 2033) of the global Growth Hormone Deficiency market?

The global Growth Hormone Deficiency market is growing at a CAGR of ~94% over the next 10 years

3. Which region has the highest growth rate in the market of Growth Hormone Deficiency?

Asia Pacific is expected to register the highest CAGR during 2023-2033

4. Which region accounted for the largest share of the market of Growth Hormone Deficiency?

North America holds the largest share in 2022

5. Major Key Players in the Market of Growth Hormone Deficiency?

Novo Nordisk A/S, Pfizer Inc, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A., Eli Lily And Company, Merck KGaA, GeneScience Pharmaceuticals Co., Ltd, and Lifetech Labs are the major companies operating in the Growth Hormone Deficiency Industry

6. Do you offer Post Sale Support?

Yes, we offer 16 hours of analyst support to solve the queries

7. Do you deliver sections of a report?

Yes, we do provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives

Table of Content

CHAPTER 1. Executive Summary

CHAPTER 2.                 Scope of the Study

2.1.        Market Definition

2.2.        Market Scope & Segmentation

2.2.1.         Objective of Report

CHAPTER 3.                 Evolve BI Methodology

3.1.        Data Collection & Validation Approach

3.2.        Market Size Estimation and Forecast

CHAPTER 4.                 Exclusive Analysis

4.1.        Market Opportunity Score

4.1.1.         Brands Segement – Market Opportunity Score

4.1.2.         Route of Administration Segment – Market Opportunity Score

4.1.3.         Application Segment – Market Opportunity Score

4.1.4.         Distribution Channel Segment – Market Opportunity Score

4.2.        Key Market Influencing Indicators

CHAPTER 5.                 Market Insights and Trends

5.1.        Value Chain Analysis

5.1.1.         Brands

5.1.2.         Manufacturing Process

5.1.3.         Distribution Channel

5.1.4.         End User

5.2.        Porter’s Five Forces Analysis

5.2.1.         Bargaining Power of Buyers

5.2.2.         Bargaining Power of Suppliers

5.2.3.         Threat of New Entrant

5.2.4.         Threat of Substitute

5.2.5.         Industry Rivalry

5.3.        COVID-19 Impact and Post COVID Scenario on Growth Hormone Deficiency Market

5.3.1.         Impact of COVID-19

5.3.2.         Government Support and Industry Revival Policies

5.3.3.         Measures Taken by Companies to Mitigate Negative Impact

5.3.4.         Post COVID Trend

CHAPTER 6.                 MArket Dynamics

6.1.        Introduction

6.2.        Drivers

6.2.1.         Driver 1

6.2.2.         Driver 2

6.2.3.         Driver 3

6.3.        Restraints

6.3.1.         Restraint 1

6.3.2.         Restraint 2

6.4.        Opportunity

6.4.1.         Opportunity 1

CHAPTER 7.                 Global Growth Hormone Deficiency Market, By Brands

7.1.        Introduction

7.1.1. Genotropin

7.1.2. Norditropin

7.1.3. Humatrope

7.1.3. Saizen

7.1.4. Omnitrope

7.1.5. Others

CHAPTER 8.                 Global Growth Hormone Deficiency Market, By Route of Administration

8.1.        Introduction

8.1.1. Subcutaneous

8.1.2. Intramuscular

8.1.3. Intravenous

8.1.4. Oral

8.1.5. Others

CHAPTER 9.                 Global Growth Hormone Deficiency Market, By Application

9.1.        Introduction

9.1.1. Growth Hormone Deficiency

9.1.2. Idiopathic Short Stature

9.1.3. Small for Gestational Age

9.1.4. Turner Syndrome

9.1.5. Prader-Willi Syndrome

9.1.6. Others

CHAPTER 10.               Global Growth Hormone Deficiency Market, By Distribution Channel

10.1.     Introduction

10.1.1 Hospital Pharmacies

10.1.2. Retail Pharmacies

10.1.3. Clinics

10.1.4. E-Commerce Websites

10.1.5. Others

CHAPTER 11.               Global Growth Hormone Deficiency Market, By Region

11.1.     Introduction

11.2.     NORTH AMERICA

11.2.1.      North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

11.2.2.      North America: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.2.3.      North America: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.2.4.      North America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.2.5.      North America: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.2.6.      US

11.2.6.1.       US: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.2.6.2.       US: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.2.6.3.       US: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.2.6.4.       US: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.2.7.      CANADA

11.2.7.1.       Canada: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.2.7.2.       Canada: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.2.7.3.       Canada: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.2.7.4.       Canada: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.2.8.      MEXICO

11.2.8.1.       Mexico: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.2.8.2.       Mexico: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.2.8.3.       Mexico: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.2.8.4.       Mexico: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.     Europe

11.3.1.      Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

11.3.2.      Europe: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.3.      Europe: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.4.      Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.5.      Europe: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.6.      U.K.

11.3.6.1.       U.K.: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.6.2.       U.K.: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.6.3.       U.K.: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.6.4.       U.K.: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.7.      GERMANY

11.3.7.1.       Germany: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.7.2.       Germany: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.7.3.       Germany: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.7.4.       Germany: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.8.      FRANCE

11.3.8.1.       France: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.8.2.       France: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.8.3.       France: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.8.4.       France: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.9.      ITALY

11.3.9.1.       Italy: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.9.2.       Italy: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.9.3.       Italy: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.9.4.       Italy: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.10.         SPAIN

11.3.10.1.     Spain: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.10.2.     Spain: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.10.3.     Spain: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.10.4.     Spain: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.11.         BENELUX

11.3.11.1.     BeNeLux: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.11.2.     BeNeLux: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.11.3.     BeNeLux: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.11.4.     BeNeLux: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.12.         RUSSIA

11.3.12.1.     Russia: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.12.2.     Russia: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.12.3.     Russia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.12.4.     Russia: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.3.13.         REST OF EUROPE

11.3.13.1.     Rest of Europe: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.3.13.2.     Rest of Europe: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.3.13.3.     Rest of Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.3.13.4.     Rest of Europe: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.     Asia Pacific

11.4.1.      Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

11.4.2.      Asia Pacific: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.3.      Asia Pacific: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.4.      Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.5.      Asia Pacific: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.6.      CHINA

11.4.6.1.       China: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.6.2.       China: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.6.3.       China: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.6.4.       China: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.7.      JAPAN

11.4.7.1.       Japan: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.7.2.       Japan: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.7.3.       Japan: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.7.4.       Japan: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.8.      INDIA

11.4.8.1.       India: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.8.2.       India: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.8.3.       India: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.8.4.       India: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.9.      SOUTH KOREA

11.4.9.1.       South Korea: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.9.2.       South Korea: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.9.3.       South Korea: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.9.4.       South Korea: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.10.         THAILAND

11.4.10.1.     Thailand: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.10.2.     Thailand: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.10.3.     Thailand: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.10.4.     Thailand: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.11.         INDONESIA

11.4.11.1.     Indonesia: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.11.2.     Indonesia: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.11.3.     Indonesia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.11.4.     Indonesia: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.12.         MALAYSIA

11.4.12.1.     Malaysia: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.12.2.     Malaysia: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.12.3.     Malaysia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.12.4.     Malaysia: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.13.         AUSTRALIA

11.4.13.1.     Australia: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.13.2.     Australia: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.13.3.     Australia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.13.4.     Australia: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.4.14.         REST FO ASIA PACIFIC

11.4.14.1.     Rest fo Asia Pacific: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.4.14.2.     Rest fo Asia Pacific: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.4.14.3.     Rest fo Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.4.14.4.     Rest fo Asia Pacific: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.5.     South America

11.5.1.      South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

11.5.2.      South America: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.5.3.      South America: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.5.4.      South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.5.5.      South America: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.5.6.      BRAZIL

11.5.6.1.       Brazil: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.5.6.2.       Brazil: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.5.6.3.       Brazil: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.5.6.4.       Brazil: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.5.7.      ARGENTINA

11.5.7.1.       Argentina: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.5.7.2.       Argentina: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.5.7.3.       Argentina: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.5.7.4.       Argentina: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.5.8.      REST OF SOUTH AMERICA

11.5.8.1.       Rest of South America: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.5.8.2.       Rest of South America: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.5.8.3.       Rest of South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.5.8.4.       Rest of South America: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.     Middle East & Africa

11.6.1.      Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

11.6.2.      Middle East & Africa: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.3.      Middle East & Africa: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.4.      Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.5.      Middle East & Africa: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.6.      SAUDI ARABIA

11.6.6.1.       Saudi Arabia: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.6.2.       Saudi Arabia: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.6.3.       Saudi Arabia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.6.4.       Saudi Arabia: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.7.      UAE

11.6.7.1.       UAE: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.7.2.       UAE: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.7.3.       UAE: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.7.4.       UAE: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.8.      EGYPT

11.6.8.1.       Egypt: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.8.2.       Egypt: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.8.3.       Egypt: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.8.4.       Egypt: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.9.      SOUTH AFRICA

11.6.9.1.       South Africa: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.9.2.       South Africa: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.9.3.       South Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.9.4.       South Africa: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

11.6.10.         REST OF MIDDLE EAST & AFRICA

11.6.10.1.     Rest of Middle East & Africa: Market Size and Forecast, By Brands, 2023 – 2033 ($ Million)

11.6.10.2.     Rest of Middle East & Africa: Market Size and Forecast, By Route of Administration, 2023 – 2033 ($ Million)

11.6.10.3.     Rest of Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)

11.6.10.4.     Rest of Middle East & Africa: Market Size and Forecast, By Distribution Channel, 2023 – 2033 ($ Million)

CHAPTER 12.               Competitive Landscape

12.1.     Competitior Benchmarking 2023

12.2.     Market Share Analysis

12.3.     Key Developments Analysis By Top 5 Companies

12.4.     Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 13.               Company Profiles

13.1.     Novo Nordisk A/S

13.1.1.      Business Overview

13.1.2.      Financial Analysis

13.1.2.1.       Business Segment Revenue, 2018, 2019, 2020, $ Million

13.1.2.2.       Geographic Revenue Mix, 2020 (% Share)

13.1.3.      Product Portfolio

13.1.4.      Recent Development and Strategies Adopted

13.1.5.      SWOT Analysis

13.2.     Pfizer Inc

13.3.     Novartis AG

13.4.     Anhui Anke Biotechnology (Group) Co., Ltd

13.5.     Biopartners GmbH

13.6.     Ipsen S.A.

13.7.     Eli Lily And Company

13.8.     Merck KGaA

13.9.     GeneScience Pharmaceuticals Co., Ltd

13.10. Lifetech Labs

Connect to Analyst

Research Methodology

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Growth Hormone Deficiency Market Research Report: By Brands (Genotropin, Norditropin, Humatrope, Saizen, Omnitrope, Others), By Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral, Others, ), By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites, Others, ), and by Region — Forecast till 2033

Page: 101

Report Published on: October 28, 2024

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033 – Single User License

$ 3,470.00

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033 – Enterprise License

$ 5,520.00

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

$ 1,390.00

Packages	Clear

Report Code: EBI11197 Categories: Life Science, Pharmaceutical

Parameters	Indicators
Market Size	2033: $6.21 Billion
CAGR	4.94% CAGR (2023-2033)
Base year	2022
Forecast Period	2023-2033
Historical Data	2021
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations	Brands, Route of Administration, Application, Distribution Channel
Geographies Covered	North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors	Novo Nordisk A/S, Pfizer Inc, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A., Eli Lily And Company, Merck KGaA, GeneScience Pharmaceuticals Co., Ltd, Lifetech Labs
Key Market Opportunities	Strong pipeline of hormonal drugs Easy availability of pharma drugs on E-commerce platforms
Key Market Drivers	Increasing cost of GHD Increasing counterfeit products for GHD treatment Rising number of strategic initiatives

Our Most Viewed Report and gain instant expertise

Clinical Trial Management System Market Analysis and Global Forecast 2023-2033 – Single User License

Clinical Trial Management System Market Analysis and Global Forecast 2023-2033 – Enterprise License

Clinical Trial Management System Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Clinical Trial Management System Market Analysis and Global Forecast 2023-2033

Clinical Trial Management System Market Research Report: Information By Product Type (Software, Services), By End User (Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, CROs, Large Pharma-biotech Companies, Other End Users, Other End Users), and by Region — Forecast till 2033 Page: 168

Select options

Quick view

Gene Therapy Market Analysis and Global Forecast 2023-2033 – Single User License

Gene Therapy Market Analysis and Global Forecast 2023-2033 – Enterprise License

Gene Therapy Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Gene Therapy Market Analysis and Global Forecast 2023-2033

Gene Therapy Market Research Report: Information By Therapy Type (Somatic, Germline), By Vector Type (Non-Viral Vectors, Viral Vectors), By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others), and by Region — Forecast till 2033

Healthcare Education Market Analysis and Global Forecast 2023-2033 – Single User License

Healthcare Education Market Analysis and Global Forecast 2023-2033 – Enterprise License

Healthcare Education Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Healthcare Education Market Analysis and Global Forecast 2023-2033

Healthcare Education Market Research Report: Information By Application (Academic Education, Cardiology, Pediatrics, Others), By Delivery Mode (Classroom based courses, E-Learning solutions), and by Region — Forecast till 2033 Page: 168

Heart Transplantation Market Analysis and Global Forecast 2023-2033 – Single User License

Heart Transplantation Market Analysis and Global Forecast 2023-2033 – Enterprise License

Heart Transplantation Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Heart Transplantation Market Analysis and Global Forecast 2023-2033

Heart Transplantation Market Research Report: Information By Surgery Type (Total Artificial Heart, Biventricular Pacing, Heart Restraint Devices, Ventricular Assist Devices, Other), By End Use (Hospitals, Cardiac institutes, Research Centers, Laboratories, Other), and by Region — Forecast till 2033

Home Medical Equipment Market Analysis and Global Forecast 2023-2033 – Single User License

Home Medical Equipment Market Analysis and Global Forecast 2023-2033 – Enterprise License

Home Medical Equipment Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Home Medical Equipment Market Analysis and Global Forecast 2023-2033

Home Medical Equipment Market Research Report: Information By Functionality (Therapeutic Equipment, Home IV Equipment, Patient Monitoring Equipment, Others),By Sales Channel (Hospital & Retail Pharmacies, Online Retailers), and by Region — Forecast till 2033 Page: 165

Inhaled Nitric Oxide Market Analysis and Global Forecast 2023-2033 – Single User License

Inhaled Nitric Oxide Market Analysis and Global Forecast 2023-2033 – Enterprise License

Inhaled Nitric Oxide Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Inhaled Nitric Oxide Market Analysis and Global Forecast 2023-2033

Inhaled Nitric Oxide Market Research Report: Information By Product Type (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Diseases, Acute Respiratory Distress Syndrome, Others), By Application (Delivery Systems, Gas), and by Region — Forecast till 2033 Page: 161

Pain Management Drugs Market Analysis and Global Forecast 2023-2033 – Single User License

Pain Management Drugs Market Analysis and Global Forecast 2023-2033 – Enterprise License

Pain Management Drugs Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Pain Management Drugs Market Analysis and Global Forecast 2023-2033

Pain Management Drugs Market Research Report: Information By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Others), By Indication (Arthritic Pain, Neuropathic Pain, Others), and by Region — Forecast till 2033 Page: 157

Wearable Patch Market Analysis and Global Forecast 2023-2033 – Single User License

Wearable Patch Market Analysis and Global Forecast 2023-2033 – Enterprise License

Wearable Patch Market Analysis and Global Forecast 2023-2033 – Data Pack Excel

Packages	Clear

Wearable Patch Market Analysis and Global Forecast 2023-2033

Wearable Patch Market Research Report: Information By Technology Outlook(Regular Wearable, Connected Wearable), By Application (Clinical, Non-clinical), and by Region — Forecast till 2033.

Page: 153

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033

Growth Hormone Deficiency Market Overview

Global Growth Hormone Deficiency Market Synopsis

Global Growth Hormone Deficiency Market Dynamics

Growth Hormone Deficiency Market Segment Overview

Global Growth Hormone Deficiency Market Regional Analysis

Growth Hormone Deficiency North America Market

Growth Hormone Deficiency Asia Pacific Market

Scope of the Report

Global Growth Hormone Deficiency Market, by Brands

Global Growth Hormone Deficiency Market, by Route of Administration

Global Growth Hormone Deficiency Market, by Application

Global Growth Hormone Deficiency Market, by Distribution Channel

Global Growth Hormone Deficiency Market, by Region

For more details mail us at

Ask a question / additional requirement

Frequently Asked Questions (FAQ)

Table of Content

Connect to Analyst

Research Methodology

Our Most Viewed Report and gain instant expertise

Wearable Patch Market Research Report: Information By Technology Outlook(Regular Wearable, Connected Wearable), By Application (Clinical, Non-clinical), and by Region — Forecast till 2033.

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Growth Hormone Deficiency Market Analysis and Global Forecast 2023-2033